NCT06299163 NM32-2668 in Adult Patients With Selected Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT06297811 Myeloprotection With Trilaciclib in Pan-cancer Population Status NOT_YET_RECRUITING Phase PHASE2
NCT06293898 Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors Status RECRUITING Phase PHASE1
NCT06293066 Performance of Ultrasound in Women With Postmenopausal or Abnormal Uterine Bleeding Between White and Black Ethnic Groups- a Retrospective Cohort Study. Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06284343 The Gynecological Cancer Associated Thrombosis (GynCAT) Study Status RECRUITING Phase N/A
NCT06279832 Radiomics and Radiogenomics Models to Predict Molecular Integrated Risk Classes and Prognostic Factors in Endometrial Cancer. Status RECRUITING Phase NA
NCT06276491 Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT06273878 From Fetal-maternal Interface Immune Tolerance to Endometrial Cancer Immune Escape: Potential Targets for Immunotherapy Status RECRUITING Phase N/A
NCT06264921 A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors Status TERMINATED Phase PHASE1
NCT06257264 A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors Status RECRUITING Phase PHASE1
NCT06253494 Pembrolizumab, Lenvatinib and IL-15 Superagonist N-803 in Combination With HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in Participants With Advanced or Metastatic Endometrial Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT06250010 Immunotolerance in Endometrial Cancer and at the Maternal-fetal Interface: Immunological Profiling of the Tumor Microenvironment in Risk Stratification of Recurrence Status RECRUITING Phase N/A
NCT06242470 A Study of MGC026 in Participants With Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT06239194 Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT06238284 HER2 Expression in Gynecological Malignant Tumors in Chongqing Area of China Status UNKNOWN Phase N/A
NCT06218914 Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors Status RECRUITING Phase PHASE1
NCT06206083 Molecular Classification in Mexican Patients With Endometrial Cancer and Its Impact on Prognosis Status RECRUITING Phase N/A